Hallux Valgus Clinical Trial
Official title:
Effects of Customized Insoles for Individuals With Symptomatic Hallux Valgus: Protocol for a Sham-controlled Randomized Trial
Hallux valgus is one of the most common forefoot deformities. Its prevalence increases with age, representing approximately 23% in adulthood, being more common in females. Some studies indicate that the use of the insole associated with the finger separator promotes pain relief and that this may be related to better alignment of the hallux. However, there is still no consensus about the ideal insole or how long it should be used to relieve pain or improve function in patients with hallux valgus. Therefore, the objective of this study will be to evaluate the effect of the customized insole on pain and function of individuals with symptomatic hallux valgus.
Status | Not yet recruiting |
Enrollment | 80 |
Est. completion date | June 1, 2026 |
Est. primary completion date | December 1, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: - Individuals of both sexes aged over 18 years; - Presence of mild to moderate hallux valgus, according to the Manchester scale; - Presenting no hallux with intensity greater than or equal to 3 points up to 8 points, according to the Numerical Pain Scale (END); - Be available to actively use the insole for at least 4 hours/day; - Commitment to wear closed shoes, for example (sneakers, shoes used by the patient, due to: wide toe cap and heel height of 2 to 3 cm) during the study. Exclusion Criteria: - Being in physical therapy treatment for hallux valgus concomitantly with the research; - Previous hallux valgus surgeries performed in the last 5 years; - Presence of foot wounds and wounds, dislocations or metatarsophalangeal fractures in the foot with HV, in the last 5 years - Presence of diseases such as rheumatoid arthritis, decompensated diabetes, gout, neurodegenerative diseases; - Cognitive and mental disorder being unable to respond; those related to the study |
Country | Name | City | State |
---|---|---|---|
Brazil | Marcelo Cardoso de Souza | Natal | RN |
Lead Sponsor | Collaborator |
---|---|
Universidade Federal do Rio Grande do Norte |
Brazil,
Costa ARA, de Almeida Silva HJ, Mendes AAMT, Scattone Silva R, de Almeida Lins CA, de Souza MC. Effects of insoles adapted in flip-flop sandals in people with plantar fasciopathy: a randomized, double-blind clinical, controlled study. Clin Rehabil. 2020 M — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Numerical Pain Scale (END) | Pain intensity will be assessed using the Numerical Pain Scale (END), in which individuals will classify their pain on a numerical scale from 0 to 10 points. This scale will be positioned in front of the participant and will vary from zero to ten points, with zero being the complete absence of pain and ten being the worst pain imaginable by the individual. The quantification of pain intensity will be evaluated at the first steps in the morning and throughout the day. | baseline, 6 weeks, 12 weeks, 16 weeks | |
Secondary | Change in Foot Function Index (FFI) | Foot functionality will be measured by the Foot Function Index (FFI) questionnaire, which is capable of measuring the impact of foot pathologies related to pain, disability and activity restriction on the function. It consists of 23 items grouped into three subscales, five items related to disability, nine items related to pain and nine items about activity limitation32. The final result will be the average of all domains (the values are added and divided by three). Results can range from 0 to 100% and are directly proportional to the functional impairment of the foot. | baseline, 6 weeks, 12 weeks, 16 weeks | |
Secondary | Change in Treatment expectation | Treatment expectations will be assessed using a 5-point Likert scale. The following will be asked to participants at T0: "Do you think that by using customized insoles, you will: 1- get much worse, 2 - get worse, 3 - no changes, 4 - improve, or 5 - greatly improve?" | baseline | |
Secondary | Change in Self-assessment of treatment | A 5-point Likert scale will be used to assess satisfaction with the intervention. Participants will be asked the following question: "How are you feeling after using the insoles?: 1- much worse, 2 - worse, 3 - no changes, 4 - better, or 5 - much better."
A 5-point Likert scale will be used to assess satisfaction with the intervention. Participants will be asked the following question: "How are you feeling after using the insoles?: 1- much worse, 2 - worse, 3 - no changes, 4 - better, or 5 - much better." |
16 weeks | |
Secondary | Change in Blinding test | Participants will be asked which group they believed they were allocated: CIG or SIG. This strategy has been recommended at the end of clinical trials to test whether the blinding strategy adopted was effective Blinding test | 16 weeks | |
Secondary | Change in Hours of insole use | Participants of both groups will receive an insole control diary to register the number of hours per day spent with the insole. Participants should keep the diary for 12 weeks and return it to researchers at T12. Monitoring and motivation will be performed via telephone or WhatsApp messages to prevent participants from forgetting to use the insole | 16 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04473196 -
The Effect of Weight Bearing on Patient Outcomes Following 1st MTP Joint Fusion
|
N/A | |
Recruiting |
NCT05555459 -
Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation
|
N/A | |
Recruiting |
NCT05587569 -
Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)
|
N/A | |
Completed |
NCT02121119 -
Lidocaine Versus Bupivacaine in Ambulatory Continuous Block With Elastomeric Pump
|
Phase 4 | |
Enrolling by invitation |
NCT00600899 -
Home Infusors for Analgesia After Foot Surgery
|
Phase 4 | |
Completed |
NCT05579054 -
Translation, Validity, and Reliability of the Foot Posture Index (FPI-6) - Turkish Version
|
||
Terminated |
NCT05082012 -
Early Weight-Bearing After the Lapiplasty Mini-Incision Procedure (Mini3D)
|
N/A | |
Recruiting |
NCT05051709 -
Can Hypermobility of First Ray Affect Surgical Treatment of Hallux Valgus
|
N/A | |
Recruiting |
NCT04716140 -
Prospective Study: The Effect on Clinical Outcome After Treatment of MTP Cartilage Lesions in Hallux Valgus Surgery
|
N/A | |
Active, not recruiting |
NCT04145882 -
Efficacy of Additional Osteotomies to Correct Hallux Valgus
|
N/A | |
Completed |
NCT04468555 -
Hallux Valgus Manual Therapy Based on Global Postural Reeducation.
|
N/A | |
Terminated |
NCT03257540 -
Early Weight-Bearing After Lapidus Arthrodesis
|
||
Completed |
NCT03846687 -
Validation of Patient Reported Outcome Measures for Use in Hallux Valgus
|
||
Completed |
NCT04365712 -
Osteotomy of the 1st Metatarsal for Hallux Valgus Using Pneumatic Oscillating Saw or Piezoelectric Scalpel
|
N/A | |
Recruiting |
NCT02282956 -
Ultrasound Guided Single Shot Block of Posterior Tibial Nerve for Postoperative Pain Relief After Hallux Valgus Surgery
|
Phase 4 | |
Withdrawn |
NCT01555216 -
Continuous Tibial Nerve Block Versus Single Shot Tibial Nerve Block
|
N/A | |
Completed |
NCT00683137 -
Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery
|
Phase 3 | |
Terminated |
NCT04103814 -
Effect of Topical CBD Cream for Degenerative Hallux Disorders
|
Phase 2/Phase 3 | |
Completed |
NCT03423498 -
The Toe-spread-out Exercise in Patients With Hallux Valgus and Without the Deformity
|
N/A | |
Not yet recruiting |
NCT06076655 -
Hallux Valgus Treatment Developed for Children With Cerebral Palsy
|
N/A |